Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2007-08-07
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S339000, C546S277700, C548S454000, C548S455000, C548S466000
Reexamination Certificate
active
11378851
ABSTRACT:
This invention relates to substituted indoline derivative compounds which are antagonists of the progesterone receptor, their preparation and pharmaceutical utility, particularly including contraception and treatment of benign or malignant neoplastic diseases, having the general structure:wherein R1and R2may be single substituents or fused to form spirocyclic rings.
REFERENCES:
patent: 3635964 (1972-01-01), Skorcz
patent: 3917592 (1975-11-01), Kobzina
patent: 4093730 (1978-06-01), Butti
patent: 4322533 (1982-03-01), Lesher et al.
patent: 4440785 (1984-04-01), Walsh
patent: 4617302 (1986-10-01), Robertson
patent: 4666913 (1987-05-01), Kuhla
patent: 4670566 (1987-06-01), Walsh
patent: 4721721 (1988-01-01), Kuhla
patent: 4822794 (1989-04-01), Spada
patent: 4831027 (1989-05-01), Narr
patent: 4853473 (1989-08-01), Fischer
patent: 4933336 (1990-06-01), Martin
patent: 5007952 (1991-04-01), Kume
patent: 5171851 (1992-12-01), Kim
patent: 5182282 (1993-01-01), Clemence
patent: 5300655 (1994-04-01), Ehrgott et al.
patent: 5414088 (1995-05-01), Von Der Saal
patent: 5447928 (1995-09-01), Williams
patent: 5453516 (1995-09-01), Fischer
patent: 5475020 (1995-12-01), Johnson
patent: 5521166 (1996-05-01), Grubb
patent: 5552412 (1996-09-01), Cameron
patent: 5565483 (1996-10-01), Hewawasam
patent: 5576330 (1996-11-01), Buzzetti et al.
patent: 5659046 (1997-08-01), Kameswaran
patent: 5681817 (1997-10-01), Hodgen
patent: 5688808 (1997-11-01), Jones
patent: 5688810 (1997-11-01), Jones
patent: 5693646 (1997-12-01), Jones
patent: 5693647 (1997-12-01), Jones
patent: 5696127 (1997-12-01), Jones
patent: 5696130 (1997-12-01), Jones
patent: 5696133 (1997-12-01), Jones
patent: 5719136 (1998-02-01), Chwalisz
patent: 5733902 (1998-03-01), Schneider
patent: 5808139 (1998-09-01), Pathirana
patent: 5874430 (1999-02-01), Christ
patent: 5952511 (1999-09-01), Esaki et al.
patent: 5998463 (1999-12-01), Hulin et al.
patent: 6031111 (2000-02-01), Esaki
patent: 6077840 (2000-06-01), Kurihara
patent: 6114536 (2000-09-01), Esaki
patent: 6127544 (2000-10-01), Esaki
patent: 6153622 (2000-11-01), Cameron
patent: 6204286 (2001-03-01), Cameron
patent: 6207836 (2001-03-01), Esaki
patent: 6306851 (2001-10-01), Santilli
patent: 6319912 (2001-11-01), Grubb
patent: 6329416 (2001-12-01), Grubb
patent: 6339098 (2002-01-01), Collins
patent: 6355648 (2002-03-01), Fensome
patent: 6358947 (2002-03-01), Zhi
patent: 6358948 (2002-03-01), Zhang
patent: 6369056 (2002-04-01), Zhang
patent: 6369086 (2002-04-01), Davis
patent: 6380178 (2002-04-01), Grubb
patent: 6380235 (2002-04-01), Zhang
patent: 6387919 (2002-05-01), Davis
patent: 6391907 (2002-05-01), Fensome
patent: 6399593 (2002-06-01), Grubb
patent: 6407101 (2002-06-01), Collins
patent: 6417214 (2002-07-01), Ullrich
patent: 6423699 (2002-07-01), Grubb
patent: 6436929 (2002-08-01), Zhang
patent: 6441019 (2002-08-01), Santilli
patent: 6441193 (2002-08-01), Cameron
patent: 6444668 (2002-09-01), Grubb
patent: 6462032 (2002-10-01), Grubb
patent: 6498154 (2002-12-01), Grubb
patent: 6503939 (2003-01-01), Grub
patent: 6509334 (2003-01-01), Zhang
patent: 6521657 (2003-02-01), Fensome
patent: 6541503 (2003-04-01), Davis
patent: 6544970 (2003-04-01), Grubb
patent: 6562857 (2003-05-01), Collinstead
patent: 6566358 (2003-05-01), Zhang
patent: 6566372 (2003-05-01), Zhi
patent: 6583145 (2003-06-01), Fensome
patent: 6608068 (2003-08-01), Fensome
patent: 6693103 (2004-02-01), Zhang
patent: 6713478 (2004-03-01), Zhang
patent: 6759408 (2004-07-01), Grubb
patent: 6794373 (2004-09-01), Grubb
patent: 6835744 (2004-12-01), Ullrich
patent: 6841568 (2005-01-01), Fensome
patent: 6946454 (2005-09-01), Fensome
patent: 6964973 (2005-11-01), Zhi
patent: 6982261 (2006-01-01), Collins
patent: 2001/0025051 (2001-09-01), Cameron
patent: 2002/0111355 (2002-08-01), Zhang
patent: 2002/0115853 (2002-08-01), Zhang
patent: 2003/0069430 (2003-04-01), Davis
patent: 2003/0092711 (2003-05-01), Zhang
patent: 2003/0220388 (2003-11-01), Fensome et al.
patent: 2004/0002535 (2004-01-01), Fensome
patent: 2004/0006060 (2004-01-01), Fensome
patent: 2004/0006122 (2004-01-01), Fensome
patent: 2004/0014798 (2004-01-01), Fensome
patent: 2004/0186101 (2004-09-01), Zhang
patent: 2005/0054711 (2005-03-01), Fensome
patent: 2005/0171186 (2005-08-01), Fensome
patent: 2005/0256110 (2005-11-01), Collins
patent: 3633861 (1988-04-01), None
patent: 4330234 (1995-03-01), None
patent: 4344463 (1995-06-01), None
patent: 022317 (1981-01-01), None
patent: 208510 (1987-01-01), None
patent: 311135 (1989-04-01), None
patent: 385850 (1990-09-01), None
patent: 483077 (1991-09-01), None
patent: 454330 (1991-10-01), None
patent: 535529 (1992-09-01), None
patent: 510235 (1992-10-01), None
patent: 947507 (1999-10-01), None
patent: 978279 (2000-02-01), None
patent: P-95-02415 (1996-11-01), None
patent: P-00-04490 (2001-03-01), None
patent: 63112584 (1988-05-01), None
patent: 2067576 (1996-10-01), None
patent: N2073671 (1997-02-01), None
patent: 95121739 (1998-02-01), None
patent: N96111002 (1998-09-01), None
patent: WO-86/03749 (1986-07-01), None
patent: WO-91/04974 (1991-04-01), None
patent: WO-91/06545 (1991-05-01), None
patent: WO-93/12085 (1993-06-01), None
patent: WO-94/14434 (1994-07-01), None
patent: WO-94/29272 (1994-12-01), None
patent: WO-95/11013 (1995-04-01), None
patent: WO 95/20389 (1995-08-01), None
patent: WO 95/20972 (1995-08-01), None
patent: WO 95/33746 (1995-12-01), None
patent: WO 96/15794 (1996-05-01), None
patent: WO 96/19458 (1996-06-01), None
patent: WO 96/19997 (1996-07-01), None
patent: WO 97/13767 (1997-04-01), None
patent: WO 97/49407 (1997-12-01), None
patent: WO 98/14436 (1998-04-01), None
patent: WO 98/27059 (1998-06-01), None
patent: WO 98/55116 (1998-12-01), None
patent: WO 99/10325 (1999-03-01), None
patent: WO 99/11264 (1999-03-01), None
patent: WO 99/15500 (1999-04-01), None
patent: WO-99/44608 (1999-09-01), None
patent: WO-01/15108 (2001-03-01), None
Wells et al., Journal of Medicinal Chemistry, 16(6), 700-703, 1973.
A. Ulmann et al, “Clinical Uses of Mifepristone (MFP)”, Ann. N.Y. Acad. Sci., 261:248 (Jun. 12, 1995).
R. Evans, “The Steroid and Thyroid Hormone Receptor Superfamily”, Science, 240:889 (May 13, 1988).
R. Kekkonen et al. “Sequential Regiment of the Antiprogesterone RU486 and Synthetic Progestin for Contraception”, Fertility and Sterility, 60(4):610 (Oct. 1993).
K. Horwitz et al., “Progestin, Progesterone Receptors, and Breast Cancer”, Horm. Cancer, publisher: Birkhaeuser, Boston, Mass., ed. Vedeckis, pp. 283-306 (1996) (abstract only).
A. Murphy et al, “Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU486”, J. Clin. Endo. Metab., 76(2):513 (Feb. 1993).
L. Kettel et al, “Endocrine Responses to Long-Term Administration of the Antiprogesterone RU486 in Patients with Pelvic Endometriosis”, Fertility and Sterility, 56(3):402 (Sep. 1991).
H. Michna et al, “Differentiation Therapy with Progesterone Antagonists”, Ann. N.Y. Acad. Sci., 761:224 (Jun. 1995).
L. Zhi et al, “5-Aryl-1,2-Dihydrochromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists”, J. Med. Chem., 41(3):291 (Oct. 22, 1998).
D. Combs et al, “Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors”, J. Med. Chem., 38:4880 (Dec. 8, 1995).
K. Perlman et al, “20-Oxopregnacalciferols: Vitamin D Compounds that Bind the Progesterone Receptor”, Tet. Letters, 35(15):2295 (1994).
L. Hamann et al, “Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists”, Ann. N.Y. Acad. Sci., 761:383 (Jun. 12, 1995).
R. Chen et al, “Synthesis and SAR of a Novel Series of Spirobenzothlzaepine Derivatives with Antiprogesterin Activity”, POI-37, 16thInt. Cong. Het. Chem., Montana (1997).
B. Narr et al, “Preparation, Testing, and Formulation of Imidazobenzoxazinones as Cardiotonics”, Chemical Abstracts, 109:22973 (1988).
R. Hartmann et al, “Effects o
Bender Reinhold H. W.
Edwards James P.
Fensome Andrew
Jones Todd K.
Miller Lori L.
Howson & Howson LLP
Milowsky Arnold S.
Powers Fiona T.
Wyeth
LandOfFree
Indoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898553